Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stalevo vs IR CD/LD on ERPs in PD
NCT00601978Phase 4Withdrawn
- Sponsor
- Novartis
- Start
- Aug 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of levodopa in Parkinson's disease (PD), sponsored by Novartis. Planned start Aug 2008; status: withdrawn.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00601978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00601978.